Pacira Pharmaceuticals, Inc. (PCRX) has 242 open-market insider trades by 50 insiders since 2011. The most active filer is David M. Stack, CEO & Chairman.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Andreas Wicki | Dir | — | 21 | $107.2M | 2021-03-15 |
| David M. Stack | CEOChairman | — | 31 | $41.1M | 2023-06-14 |
| Luke Evnin | Dir | — | 6 | $33.1M | 2013-06-13 |
| Beteiligungs GmbH & Co Kg Sanderling VI | Dir | — | 2 | $19.8M | 2013-03-19 |
| Vaughn M. Kailian | — | — | 2 | $13.9M | 2013-03-11 |
| Vort John Vander | — | — | 1 | $13.9M | 2013-03-11 |
| Kristen Marie Williams | CAO | — | 21 | $13.8M | 2023-06-14 |
| Sanderling Venture Partners VI LP | 10% | — | 2 | $10.7M | 2013-03-15 |
| Gary W. Pace | Dir | — | 8 | $9.6M | 2024-03-08 |
| Venture Partners Vi Co Investment Fund Lp Sanderling | 10% | — | 1 | $9.5M | 2013-01-24 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Lauren Riker | President & VP | Sell | $218K | 2026-10-08 |
| Jonathan Slonin | — | Sell | $71K | 2026-08-17 |
| Lauren Riker | President & VP | Sell | $144K | 2026-06-11 |
| Kristen Williams | CAO | Sell | $228K | 2026-06-04 |
| Shawn Cross | CFO | Sell | $326K | 2026-04-23 |
| Shawn Cross | CFO | Sell | $303K | 2026-04-20 |
Companies that share insiders with PCRX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Mark Froimson | Director | Sell | $11K | 2026-03-17 |
| Jonathan Slonin | — | Sell | $74K | 2026-03-17 |
| Lauren Riker | President & VP | Sell | $83K | 2026-02-02 |
| Kristen Williams | Chief Administrative Officer | Sell | $270K | 2026-02-02 |
| Lauren Riker | President & VP | Sell | $34K | 2026-01-05 |
| Shawn Cross | CFO | Sell | $1.3M | 2025-12-09 |
| Jonathan Slonin | — | Sell | $191K | 2025-11-17 |
| Shawn Cross | CFO | Sell | $533K | 2025-11-10 |
| Abraham Ceesay | Director | Sell | $128K | 2025-09-04 |